A detailed history of Rhumbline Advisers transactions in Beauty Health CO stock. As of the latest transaction made, Rhumbline Advisers holds 113,439 shares of SKIN stock, worth $170,158. This represents 0.0% of its overall portfolio holdings.

Number of Shares
113,439
Previous 114,986 1.35%
Holding current value
$170,158
Previous $510,000 57.45%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

SELL
$1.77 - $4.28 $2,738 - $6,621
-1,547 Reduced 1.35%
113,439 $217,000
Q1 2024

May 09, 2024

BUY
$2.39 - $4.53 $6,878 - $13,037
2,878 Added 2.57%
114,986 $510,000
Q4 2023

Feb 08, 2024

SELL
$1.39 - $5.86 $661 - $2,789
-476 Reduced 0.42%
112,108 $348,000
Q3 2023

Nov 09, 2023

SELL
$5.47 - $8.78 $5,377 - $8,630
-983 Reduced 0.87%
112,584 $677,000
Q2 2023

Aug 08, 2023

SELL
$7.77 - $13.7 $33,107 - $58,375
-4,261 Reduced 3.62%
113,567 $950,000
Q1 2023

May 11, 2023

SELL
$9.22 - $13.3 $73,326 - $105,774
-7,953 Reduced 6.32%
117,828 $1.49 Million
Q4 2022

Feb 14, 2023

BUY
$8.39 - $13.4 $2,391 - $3,819
285 Added 0.23%
125,781 $1.15 Million
Q3 2022

Nov 10, 2022

BUY
$10.35 - $15.27 $106,149 - $156,609
10,256 Added 8.9%
125,496 $1.48 Million
Q2 2022

Aug 11, 2022

BUY
$10.6 - $17.48 $270,967 - $446,841
25,563 Added 28.51%
115,240 $1.48 Million
Q1 2022

May 12, 2022

BUY
$12.24 - $24.07 $69,780 - $137,223
5,701 Added 6.79%
89,677 $1.51 Million
Q4 2021

Feb 10, 2022

SELL
$20.7 - $29.49 $17,388 - $24,771
-840 Reduced 0.99%
83,976 $2.03 Million
Q3 2021

Nov 12, 2021

BUY
$16.76 - $28.26 $665,271 - $1.12 Million
39,694 Added 87.97%
84,816 $2.2 Million
Q2 2021

Aug 05, 2021

BUY
$9.91 - $18.8 $447,159 - $848,293
45,122 New
45,122 $758,000

Others Institutions Holding SKIN

About Beauty Health Co


  • Ticker SKIN
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Household & Personal Products
  • Shares Outstandng 150,887,008
  • Market Cap $226M
  • Description
  • The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Hydra...
More about SKIN
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.